Multiple copies of RUNX1: description of 14 new patients, follow-up, and a review of the literature


Por: Pérez-Vera P., Montero-Ruíz O., Frías S., Rivera-Luna R., Valladares A., Arenas D., Paredes-Aguilera R., Carnevale A.

Publicada: 15 ene 2008
Resumen:
RUNX1 over-representation is present in children with acute lymphoblastic leukemia. Although these cases have been related with poor outcome, not all reports describe patient follow-up. To understand its associated clinical features and prognosis, we report on 14 children with ALL and RUNX1 over-representation with laboratory data and outcomes compared to previous reports. Eighty-six children with RUNX1 over-representation have been described, including the 14 patients of this study. Most of them are between 6 and 15 years of age, have low leukocyte counts, pre-B immunophenotype, and three to eight RUNX1 copies. Of the 69 patients-with follow-up data, 21 of them relapsed or died, suggesting that RUNX1 over-representation is associated to a poor outcome. (C) 2008 Elsevier Inc. All rights reserved.

Filiaciones:
Pérez-Vera P.:
 Departamento de Investigación en Genética Humana, Instituto Nacional de Pediatría, Insurgentes Sur No. 3700-C, Col. Insurgentes Cuicuilco, CP 04530 Mexico, D.F., Mexico

Montero-Ruíz O.:
 Departamento de Investigación en Genética Humana, Instituto Nacional de Pediatría, Insurgentes Sur No. 3700-C, Col. Insurgentes Cuicuilco, CP 04530 Mexico, D.F., Mexico

Frías S.:
 Departamento de Investigación en Genética Humana, Instituto Nacional de Pediatría, Insurgentes Sur No. 3700-C, Col. Insurgentes Cuicuilco, CP 04530 Mexico, D.F., Mexico

Rivera-Luna R.:
 Subdirección de Hemato-Oncología, Instituto Nacional de Pediatría, Insurgentes Sur No. 3700-C, Col. Insurgentes Cuicuilco, CP 04530 Mexico, D.F., Mexico

Valladares A.:
 Unidad de Investigación Médica en Bioquímica, Centro Médico Nacional Siglo XXI, Av. Cuauhtamoc No. 330, Col. Doctones, CP 06725 Mexico, D. F., Mexico

Arenas D.:
 Laboratorio de Genética Molecular, UIM Genética Humana, Hospital de Pediatría, Av. Cuauhtamoc No. 330, Col. Doctones, CP 06725 Mexico, D. F., Mexico

Paredes-Aguilera R.:
 Subdirección de Hemato-Oncología, Instituto Nacional de Pediatría, Insurgentes Sur No. 3700-C, Col. Insurgentes Cuicuilco, CP 04530 Mexico, D.F., Mexico

Carnevale A.:
 Coordinación Nacional de Medicina Genómica, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Av. San Fernando No. 547 Col. Toriello Guerra, CP 19050 Mexico, D. F. Mexico City,, Mexico
ISSN: 01654608
Editorial
ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA, Estados Unidos America
Tipo de documento: Review
Volumen: 180 Número: 2
Páginas: 129-134
WOS Id: 000252841800006
ID de PubMed: 18206538